86 related articles for article (PubMed ID: 7168306)
21. Lycopene inhibits DNA damage and liver necrosis in rats treated with ferric nitrilotriacetate.
Matos HR; Capelozzi VL; Gomes OF; Mascio PD; Medeiros MH
Arch Biochem Biophys; 2001 Dec; 396(2):171-7. PubMed ID: 11747294
[TBL] [Abstract][Full Text] [Related]
22. Cholesterol as target of Fe-NTA-induced lipid peroxidation in rat tissues.
Rosa A; Deiana M; Corona G; Atzeri A; Incani A; Dessì MA
Toxicol Lett; 2005 May; 157(1):1-8. PubMed ID: 15795088
[TBL] [Abstract][Full Text] [Related]
23. Different patterns of kidney toxicity after subacute administration of Na-nitrilotriacetic acid and Fe-nitrilotriacetic acid to Wistar rats.
Bahnemann R; Leibold E; Kittel B; Mellert W; Jäckh R
Toxicol Sci; 1998 Nov; 46(1):166-75. PubMed ID: 9928680
[TBL] [Abstract][Full Text] [Related]
24. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats.
Ebina Y; Okada S; Hamazaki S; Ogino F; Li JL; Midorikawa O
J Natl Cancer Inst; 1986 Jan; 76(1):107-13. PubMed ID: 3455733
[TBL] [Abstract][Full Text] [Related]
25. Induction of renal oxidative stress and cell proliferation response by ferric nitrilotriacetate (Fe-NTA): diminution by soy isoflavones.
Khan N; Sultana S
Chem Biol Interact; 2004 Aug; 149(1):23-35. PubMed ID: 15294441
[TBL] [Abstract][Full Text] [Related]
26. Antioxidant biofactor, a processed grain food, inhibits iron nitrilotriacetate-induced renal tumorigenesis, hyperproliferative response, and oxidative damage.
Mizote A; Okazaki Y; Iqbal M; Okada S
Hum Exp Toxicol; 2008 Mar; 27(3):207-14. PubMed ID: 18650252
[TBL] [Abstract][Full Text] [Related]
27. Translocation of Bax in rat hepatocytes cultured with ferric nitrilotriacetate.
Yajun Z; Hongshan C; Baoxi S; Dengbing Y; Jianhua S; Xinshun G; Li Y; Yi C
Life Sci; 2005 Apr; 76(24):2763-72. PubMed ID: 15808878
[TBL] [Abstract][Full Text] [Related]
28. Age-related differences in iron-nitrilotriacetate hepatotoxicity in the guinea pig: role of copper metallothionein.
Suntres ZE; Lui EM
J Pharmacol Exp Ther; 1991 Sep; 258(3):797-806. PubMed ID: 1890621
[TBL] [Abstract][Full Text] [Related]
29. Enhanced induction of hepatic lipid peroxidation by ferric nitrilotriacetate in chickens susceptible to fatty liver rupture.
Squires EJ; Wu J
Br Poult Sci; 1992 May; 33(2):329-37. PubMed ID: 1623419
[TBL] [Abstract][Full Text] [Related]
30. Appearance of iron free hyperplastic hepatocytes following ferric nitrilotriacetate and 2-acetaminofluorene sequential administration.
Malvaldi G
Eur J Cancer (1965); 1981 Apr; 17(4):481-3. PubMed ID: 7308257
[No Abstract] [Full Text] [Related]
31. Ferric nitrilotriacetate: a potent stimulant of in vivo lipid peroxidation in mice.
Goddard JG; Sweeney GD
Biochem Pharmacol; 1983 Dec; 32(24):3879-82. PubMed ID: 6661264
[No Abstract] [Full Text] [Related]
32. Garlic oil ameliorates ferric nitrilotriacetate (Fe-NTA)-induced damage and tumor promotion: implications for cancer prevention.
Agarwal MK; Iqbal M; Athar M
Food Chem Toxicol; 2007 Sep; 45(9):1634-40. PubMed ID: 17512651
[TBL] [Abstract][Full Text] [Related]
33. Renoprotective effects of sesamol in ferric nitrilotriacetate-induced oxidative renal injury in rats.
Gupta A; Sharma S; Kaur I; Chopra K
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):316-21. PubMed ID: 19281599
[TBL] [Abstract][Full Text] [Related]
34. An electron microscopical and histochemical study on ferric nitrilotriacetate-induced "F1 amyloidosis".
Ogura M; Toki J; Maeda R
Acta Pathol Jpn; 1986 May; 36(5):715-32. PubMed ID: 3739706
[TBL] [Abstract][Full Text] [Related]
35. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate.
Li JL; Okada S; Hamazaki S; Ebina Y; Midorikawa O
Cancer Res; 1987 Apr; 47(7):1867-9. PubMed ID: 3815378
[TBL] [Abstract][Full Text] [Related]
36. [Oral subchronic toxicity studies of ferric chloride in F344 rat].
Sato H; Toyoda K; Furukawa F; Kokubo T; Takahashi M; Hayashi Y
Eisei Shikenjo Hokoku; 1985; (103):21-8. PubMed ID: 3830310
[No Abstract] [Full Text] [Related]
37. Oxidative stress response in iron-induced renal carcinogenesis: acute nephrotoxicity mediates the enhanced expression of glutathione S-transferase Yp isozyme.
Fukuda A; Osawa T; Oda H; Toyokuni S; Satoh K; Uchida K
Arch Biochem Biophys; 1996 May; 329(1):39-46. PubMed ID: 8619633
[TBL] [Abstract][Full Text] [Related]
38. Free radical-mediated effects on skeletal muscle protein in rats treated with Fe-nitrilotriacetate.
Nagasawa T; Hatayama T; Watanabe Y; Tanaka M; Niisato Y; Kitts DD
Biochem Biophys Res Commun; 1997 Feb; 231(1):37-41. PubMed ID: 9070215
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of prior low dose X-ray irradiation on Fe(3+)-NTA-induced hepatopathy in rats.
Yamaoka K; Nomura T; Iriyama K; Kojima S
Physiol Chem Phys Med NMR; 1998; 30(1):15-23. PubMed ID: 9807233
[TBL] [Abstract][Full Text] [Related]
40. A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney.
Uchida K; Fukuda A; Kawakishi S; Hiai H; Toyokuni S
Arch Biochem Biophys; 1995 Mar; 317(2):405-11. PubMed ID: 7893156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
